The Patent Finder

Amgen British Columbia

Also on record
Records under this name other than patents Amgen British Columbia holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Amgen British Columbia

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,779,108Targeted Binding Agents Against B7-H1
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,400,039Targeted Binding Agents Against B7-H1
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,518,809Targeted Binding Agents Against B7-H1
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,941,211Anti-Gcc Antibody Molecules and Related Compositions and Methods
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,493,565Targeted Binding Agents Against B7-H1
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,785,600Anti-Gcc Antibody Molecules and Related Compositions and Methods
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,119,130Targeted Binding Agents Directed to KDR and Uses Thereof - 035
Formerly held
Lapsed on the fee record
Ended Feb 21, 2024 · High confidence
Lapsed on the fee recordEnded Feb 21, 2024High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited